BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 11956271)

  • 1. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
    Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
    J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease: complications of therapy and excess mortality.
    Hoppe RT
    Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mortality after successful treatment for Hodgkin's disease.
    Hudson MM; Poquette CA; Lee J; Greenwald CA; Shah A; Luo X; Thompson EI; Wilimas JA; Kun LE; Crist WM
    J Clin Oncol; 1998 Nov; 16(11):3592-600. PubMed ID: 9817280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
    Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.
    Bodis S; Henry-Amar M; Bosq J; Burgers JM; Mellink WA; Dietrich PY; Dupouy N; Noordijk EM; Raemaekers JM; Thomas J
    J Clin Oncol; 1993 Feb; 11(2):225-32. PubMed ID: 8426198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
    Gocheva L; Koleva I
    Klin Onkol; 2010; 23(1):34-42. PubMed ID: 20192072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cause-specific mortality of patients treated for Hodgkin's disease.
    Aleman BM; van den Belt-Dusebout AW; Klokman WJ; Van't Veer MB; Bartelink H; van Leeuwen FE
    J Clin Oncol; 2003 Sep; 21(18):3431-9. PubMed ID: 12885835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of prognostic factors of Hodgkin's disease with Cox model].
    Gui W; Zhen YP; Chang XQ
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):751-3. PubMed ID: 7600864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
    Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
    Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of competing risks of causes of death and their variation over different time periods in Hodgkin's disease.
    Provencio M; Millán I; España P; Sánchez AC; Sánchez JJ; Cantos B; Vargas JA; Bellas C; García V; Sabin P; Bonilla F
    Clin Cancer Res; 2008 Aug; 14(16):5300-5. PubMed ID: 18698050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.